Increased hemoglobin and thrombocytocrit in non-alcoholic fatty liver disease

Objective: Complete blood count (CBC) test is a simple, universally used, inexpensive marker used in clinical practices, however, few study focused on the relationship between CBC and non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to assess the relationship between them. Materials and methods: Four hundred and forty subjects (223 men and 217 women) participated in a routine medical checkup and were chosen to be included in this study. Measurements such as weight, height, BMI, and blood pressure were recorded. Serum biochemical indicators were measured, and an ultrasound of the liver was obtained. CBC test was performed, including measurements of white cell count, red cell count, platelet count and hemoglobin. Results: Measurements of weight, BMI and blood pressure were significantly higher in the NAFLD patients compared to that of controls. The level of alanine aminotransferase, aspartate aminotransferase acetylcholinesterase, gamma glutamil transferase, triglyceride, total cholesterol, fasting plasma glucose and uric acid was significantly higher in NAFLD patients than that of healthy controls. The level of HDL-cholesterol was lower in NAFLD patients compared to healthy controls. The level of hemoglobin and the percent of the thrombocytocrit were significantly higher in NAFLD patients compared to controls. However, differences in white blood cell count, red cell count and blood platelet count were not significant between NAFLD and healthy controls. Conclusions: Increased hemoglobin and thrombocytocrit level were found in NAFLD patients. Clinicians should be aware of this kind of alterations in complete blood count.